ArticleJournal of medical biochemistry2026
Diagnostic value of combined detection of serum NLR and CRP for migraine patients in the attack stage: A prospective study.
Article in Journal of medical biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nitric Oxide, Oxidative Stress and Endothelial Dysfunction in Migraine: Recent Advances and Molecular Mechanisms.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We attempted to clarify the diagnostic value of combined detection of neutrophil-to-lymphocyte ratio (NLR) and serum C-reactive protein (CRP) for migraine patients in the attack stage. Methods: A total of 50 migraine patients in the attack stage undergoing treatment in our hospital from June 2023 to June 2024 were chosen as the observation group. Additionally, 50 healthy individuals undergoing physical examination in our hospital were chosen as the control group. We adopted questionnaires to obtain detailed demographic data, medical history, and disease characteristics of patients. The patients and healthy examinees received routine blood tests without prior medication within 3 hours after admission. The absolute values of neutrophils (N) and lymphocytes (L) were obtained, followed by calculation of the neutrophil-to-lymphocyte ratio (NLR). The serum C-reactive protein (CRP) level was measured using immuno-nephelometry. The diagnostic value of NLR and serum CRP for migraine was analysed using the receiver operating characteristic (ROC) curve. Results: The serum CRP and NLR levels were significantly higher in the observation group compared with the control group (P< 0.05). In the observation group, serum CRP and NLR levels in patients with migraine with aura were comparable to those in patients without aura, with no significant difference (P> 0.05). Similarly, differences in serum CRP and NLR levels between patients with frequent migraine attacks and those with infrequent attacks were not statistically significant (P> 0.05). Serum CRP or NLR alone could be used to diagnose migraine patients in the attack stage, and there was no significant difference between them in diagnostic accuracy (P= 0.633). However, combined detection of serum CRP and NLR showed a significantly higher diagnostic value than either marker alone. Conclusions: The inflammatory biomarkers serum CRP and NLR were markedly elevated in migraine patients during the attack stage. The combination of serum CRP and NLR has diagnostic value in identifying migraine attacks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.